ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
A proliferation of articles published last year questioned whether Americans were eating too much protein. Experts we ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
How can food and drink brands make the most out of female health needs? FoodNavigator explores the opportunities around the ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results